LIVE
News

US Senate Confronts the Menopause Care Gap in Historic First Hearing

For the first time, a U.S. Senate committee convened a hearing dedicated to menopause care and research, putting the so-called "menopause care gap" on the congressional record.

Miranda Hendrix·updated September 19, 2026

US Senate Confronts the Menopause Care Gap in Historic First Hearing

Witnesses included clinicians from the American College of Obstetricians and Gynecologists alongside policy advocates, framing the conversation around research funding shortfalls, physician training gaps, and insurance barriers. For those of us working in holistic and naturopathic care, the hearing signals a shift: mainstream medicine is finally acknowledging what patients have navigated largely on their own for decades.

What the hearing surfaced

According to coverage from CNN distributed via KNOE, the hearing drew statements from senators in both parties. Sen. Kirsten Gillibrand (D-N.Y.) told the committee, "Women have carried this alone for generations. Not anymore." Sen. Rick Scott (R-Fla.) added, "There's simply no excuse for the lack of resources and information."

Witness testimony centered on three measurable gaps. Jennifer Weiss-Wolf of the Birnbaum Women's Leadership Center at NYU Law noted that less than 1% of federal research funding goes to menopause and midlife women's health. Dr. Lynne Coslett-Charlton, representing ACOG, told the panel, "There's no reason that we have to tough this out," and pushed for broader access to therapies that can improve quality of life and reduce debilitating symptoms. Dr. Suzanne Silverman Fenske, a practicing gynecologist, disclosed that her own OB-GYN education focused largely on reproductive issues and pregnancy, with very little menopausal training in the core curriculum.

Why this lands in our lane

I often see women arrive at my practice after years of being told their symptoms are simply part of aging. Sleep disruption, joint stiffness, mood shifts, changes in cycle rhythm — these are treatable patterns, not personality flaws. Congressional acknowledgment that physician education and research dollars have neglected this stage of life reinforces what many of you already suspect: the system has not caught up with the biology.

The hearing also flagged shortages of certain hormone treatments and gaps in insurance coverage. Coslett-Charlton emphasized that access to effective therapy should not be limited to those who can afford it. For an integrative approach, that framing matters. Whole-food nutrition, botanical support, movement, and stress regulation are foundational, and they tend to work best when conventional hormone options remain accessible and well-prescribed rather than rationed by cost or supply.

What to watch

The hearing is procedural, not legislative, based on the available reporting. The practical outcome is momentum: a public record, named barriers, and bipartisan language. I would watch three things next — any follow-up hearing or markup, the next federal research budget allocation for midlife women's health, and whether ACOG and other bodies expand menopause content in residency curricula.

For now, you can use this moment practically. Bring the language now in the record — care gap, research funding, physician training — into your next appointment, whether with a gynecologist, a primary care provider, or an integrative clinician. It reframes the conversation from a personal complaint to a documented public health issue, and it gives your provider a shared vocabulary to work with.